Imp3 expression determines aggressive superficial urothelial carcinoma

Access through your institution Buy or subscribe Sitnikova L _ et al_. (2008) IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. _Clin Cancer Res_ 14: 1701–1706

Predicting the risk of tumor progression in superficial urothelial carcinoma is currently difficult. Sitnikova _ et al_. have examined the utility of using IMP3—an oncofetal protein—as a

biomarker to distinguish between tumors with a high probability of progression and those that are unlikely to become invasive. This is a preview of subscription content, access via your

institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this

article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in

* Learn about institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE IMP3 expression

determines aggressive superficial urothelial carcinoma. _Nat Rev Clin Oncol_ 5, 364 (2008). https://doi.org/10.1038/ncponc1142 Download citation * Issue Date: July 2008 * DOI:

https://doi.org/10.1038/ncponc1142 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently

available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative